NTRA MEXC RealStocks
Own real NTRA shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 12:26:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Natera, Inc. (NTRA) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $320.66, with a market capitalization of $45.24B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $181.00 to $437.41. This page covers its latest market performance, valuation, price trends and company information.
$45.24B | |
$321.45 | |
$326.98 | |
$319.04 | |
$319.82 | |
1.64K | |
1.71M | |
-- | |
$437.41 | |
$181.00 | |
-- | |
12-31 |
Natera, Inc. (NTRA) is trading at $320.66 in pre-market trading as of 2026-11-12 12:23:00, up 0.26% ($0.84) from the previous close of $319.82
Pre-market trading shows how investors are pricing NTRA before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Natera, Inc. (NTRA) moved from $388.63 to $320.66, representing a decline of 17.49% ($67.97).
The stock traded between $304.00 and $398.03 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.14 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 54.5%
NTRA is currently trading at $320.66, placing it 54.5% of the way from its 52-week low of $181.00 to its 52-week high of $437.41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 6,140 |
| CEO | Solomon Moshkevich |
| Founded | 2003 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Natera, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Natera, Inc. (NTRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to NTRA, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between NTRA shares and USD.
NTRA Shares to USD
1.00 NTRA shares = 320.66 USD
Calculations are estimates based on the latest available price and are for reference only.